Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Investigation of the mechanisms of sonodynamic therapy

Singh K. and Oppermann U., (2024)

Altered hormone and bioactive lipid plasma profile in rodent models of polycystic ovarian syndrome revealed by targeted mass spectrometry

Scott HC. et al, (2024)

Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma.

Van Oekelen O. et al, (2024), Cell rep med, 5

A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding

Wang C. et al, (2024)

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

Twumasi C. et al, (2023), Eur j haematol

KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics.

Mouti MA. et al, (2023), Nat commun, 14

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Kurata K. et al, (2023), Blood cancer j, 13

Long-Read Single-Cell Sequencing Using scCOLOR-seq.

Philpott M. et al, (2023), Methods mol biol, 2632, 259 - 267

Recognition of Dimethylarginine Analogues by Tandem Tudor Domain Protein Spindlin1

Porzberg MRB. et al, (2022), Molecules, 27, 983 - 983

Nanopore sequencing of single-cell transcriptomes with scCOLOR-seq.

Philpott M. et al, (2021), Nat biotechnol, 39, 1517 - 1520

First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.

Nowak RP. et al, (2021), J med chem

Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.

Tapmeier TT. et al, (2021), Sci transl med, 13

Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.

Tapmeier TT. et al, (2021), Sci transl med, 13

AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation.

Uğurlu-Çimen D. et al, (2021), Epigenetics chromatin, 14

Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma.

Ohguchi H. et al, (2021), Cancer discov, 2, 370 - 387

KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.

Heward JA. et al, (2021), Blood

The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection.

Sandoval DR. et al, (2021), Biorxiv

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

NIBHANI R., (2021), Nature communications

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

OPPERMANN UDO., (2021), Nature communications

A Chemo-Genomic Approach Identifies Diverse Epigenetic Therapeutic Vulnerabilities in MYCN-Amplified Neuroblastoma.

Krstic A. et al, (2021), Front cell dev biol, 9

Load More